EPO and chronic kidney disease: Iron stores may not be controlled in a particular patient until the development of anemia resistant to increasing doses of Epo, besides serum iron markers may be difficult to interpret due to the fact that ferritin is an acute-phase reactant which may disrupt the interpretation of ID in CKD patients47,48.